Spectrum To Complete Levofolinic Acid NDA In Q1 2007 Following Acquisition
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Spectrum hopes to launch the active isomer form of leucovorin, levofolinic acid, in late 2007 following acquisition of the compound from private firm Targent, announced March 20